View Cart (0 items)

Pharmaceutical

Endo Pharmaceuticals settles lawsuit over unlawful marketing

No Comments
Pharmaceutical companies Endo Pharmaceuticals and Endo Health Solutions will have to pay $192.7 million to resolve criminal and civil charges related to their marketing policy for the product Lidoderm.
Read More

AstraZeneca, Merck gain share on Glaxo's asthma treatment drug

No Comments
Competition on the U.S. pharmaceutical market has never been more fierce. Generic drugs are taking decisive steps onto the market, gaining a bigger share wherever they are allowed.
Read More

Plastics, polymers to dominate global pharmaceutical packaging market

No Comments
Over the years through 2018, the global pharmaceutical packaging market is predicted to reach $78.79 billion, with Europe, Japan and the U.S. accounting for about 70% of the entire market.
Read More

Mexico's Neolpharma opens R&D facility in Puerto Rico

No Comments
The Center for the Development and Innovation of Pharmaceutical Products, or Cediprof, will focus on research and experimentation of generic drugs.
Read More

Another Ranbaxy facility lands on FDA blacklist

No Comments
The U.S. Food and Drug Administration (FDA) has added Ranbaxy's Toansa plant to the list of Indian facilities included on the consent decree dated January 2012.
Read More

Novo Nordisk locked in legal battle over generic drug

No Comments
Danish pharmaceutical giant Novo Nordisk is being sued by several healthcare purchasing companies that claim the drug maker wrongfully kept generic copies of its diabetes drug Prandin off the market.
Read More

US pharmaceutical spending slightly down from 2012 levels

No Comments
Expenditure on pharmaceuticals in 2013 is predicted to register a minor decline of 0.5% dipping to $341.2 billion from $343 billion in 2012.
Read More

Global spending on medicines to grow by up to 6% per year through 2017

No Comments
The key factors that will drive global drug markets are better access to medicines due to rising disposable income in developing countries and more favorable economic conditions in emerging markets.
Read More

FDA imposes new ban on Wockhardt drugs

No Comments
Indian generic drug maker Wockhardt has been hit by a U.S. import alert for the second time this year.
Read More

FDA seeks to ban dietary supplements unlawfully marketed as drugs

No Comments
The U.S. Food and Drug Administration has taken administrative action against a dietary supplement manufacturer following multiple breaches of the Federal Food, Drug and Cosmetic Act.
Read More